NPPA notified regarding the Computation of Retail Price of Moxifloxacin Hydrochloride BP eq. to Moxifloxacin 0.5% w/v + Dexamethasone Sodium Phosphate IP 0.1% w/v

May 23, 2024 | by TeamLease RegTech Legal Research Team

Free Legal updates for the week 00


Industry Specific ComplianceThe National Pharmaceutical Pricing Authority (NPPA) on May 21, 2024, issued the notification regarding the Computation of Retail Price of Moxifloxacin Hydrochloride BP eq. to Moxifloxacin 0.5% w/v + Dexamethasone Sodium Phosphate IP 0.1% w/v.

The following has been stated namely: -

• The Retail Price is computed based on Data from October, 2023

• The retail price is computed for Each film coated tablet containing: Moxifloxacin Hydrochloride BP eq. to Moxifloxacin 0.5% w/v + Dexamethasone Sodium Phosphate IP 0.1% w/v for M/s. Aurolab (Manufacturer & Marketer)

• The Sum of MAT value considered for price calculation is 77,12,10,614

[Notification No. 19(3985)/2024/DP/NPPA/DIV.II]


Bookmark

Related Updates



Alternate Text

Get updates on the go on RegUpdate Mobile App.

NEW  ·  AI ASSISTANT